Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It was 1000 shares 1k = $24,000 = PRESENTS ..He still has 63,108 = $1.5 million ( + options )
I had thought StockVader would have made an appearance by now.
In accordance with my wild assumption about the planned & approved use of a commonplace 120 calendar for data statistical analysis, negative results were most likely to be reported this afternoon and that outcome window is now closed.
I am uninterested in NWBO comparisons that are dependent upon the continuing unknowns of whether statistical analysis of the data from its clinical trial has been arranged & enacted.
On day 121 of post data lock analysis cel-sci listed an employment opening for a supervisor of Quality Control. Did this signal the beginning for the evaluation of statistical analysis by the company (its scientists & legal team included) for its formulation & drafting of its study results public disclosure?
The idea of a time indefinite contract between the CRO & its contracted independent statistical reviewers is unfathomable.
There really is no reason why CVM or Kersten should not know or have had input on CRO affiliated contract deadlines.
IF I were a CEO who had known to expect a substantial increase in workload & global business travel as a result company milestones, I would time such expectations to coincide with when I was freshest...
Or so I've gambled in continued anticipation of the research investment market efficiency importance of publishing & presentation to the American Society of Clinical Oncology.
I'd think that the 2500 smarttanks mentioned in the LOI are primarily intended for their installation & tech specialists whose input is essential to ensuring tech manual specificity.
Is the IOT SmartTank App field test more about established & standardized IOT reliability or about the chemical company determining finer details for service product marketing & giving their legal department time to codify necessary changes to service contracts?
I am inclined to expect April revenues to have a noticeable bump up solely in response to the "field tests".
Perspective: What is the over/under for revenue exceeding $5 million for the month of March?
How long can you hold your breath?
Perspective: What is the over/under for revenue exceeding $5 million for the month of March?
How long can you hold your breath?
$ALYI has priced itself with its $100 million RevoltToken transfer ownership plan. Isn't $IQST the most likely partner/ suitor with the managerial competence to profitably bring the bike to market? Why should $IQST limit its interest in the project to $200/ battery on a product whose current ownership has an extremely insecure path for realizing profitable production?
$ALYI has priced itself with its $100 million RevoltToken transfer ownership plan. Isn't $IQST the most likely partner/ suitor with the managerial competence to profitably bring the bike to market? Why should $IQST limit its interest in the project to $200/ battery on a product whose current ownership has an extremely insecure path for realizing profitable production?
I wasn't wr, wr, wro, wro...
December 7th, 2020 PR did in fact make march 18th a nearly drop dead date for publishing study findings. Now should I weigh with emphasis how the late data may de-prioritize placement at ASCO in June as an indicator of increased risk? Will short traders prop the stock price up to play bagholder games?
Probably far left field thinking, but doesn't ASCO late abstract submission criteria explicitly exclude TLD? https://meetings.asco.org/am/late-breaking-data-submission-guidelines
It would be shameful, regardless of study results, if $CVM's multikine study did not factor into ASCO this June.
So if I formed a developmental stage pharmaceutical company founded on the notion that a patented retinoic compound that has crossed the blood brain barrier & produced neurogenesis by regulating N-acetylaspartate balance in rat models & then funded my research with share selling loan agreements requiring me to contract a Transfer Agent earning commissions based upon the daily volume of shares exchanged, at what point in future time of me not bringing a product to market would you call my company a "scam"?
I am creating an analogy between patents for biologicals & the value & risks associated with business relationships in underdeveloped markets that are made and exposed as deficient by the whims of geopolitical tensions & economic gamesmanship.
The word "scam" is being tossed around too freely. Most business ideas fail to gain traction. This does not mean that their paper/debt trading or business failure delegitimizes & criminalizes the endeavor. If I wanted, I could incorporate a personal newspaper, establish credit for it, obtain a DUNS number by soliciting DUNS & Bradstreet, & then sell shares in a desperate quest to make a media empire (all while earning a meager living from the activities).
The word "scam" is being tossed around too freely. Most business ideas gain traction. This does not mean the paper/debt trading or business failure delegitimizes & criminalizes those endeavors. If I wanted, I could incorporate a personal newspaper, establish credit for it, obtain a DUNS number by soliciting DUNS & Bradstreet, & then sell shares in a desperate quest to make a media empire (all while earning a meager living from the activities).
If Dabrowski, on the other hand, has been accumulating a fortune of Bitcoin, all hands on deck.
$ALYI management's ambitious EV planning is realizable. Clearly, they are intelligent enough to understand that they must produce Audited financials & increase their accountability to shareholders & cryptocurrency owners by making themselves & the company fully subject to the broadest & finest details of regulatory oversight.
I expect the current CEO to fall on his sword implementing an increase to Authorized Shares to make sure the financials are audited. And, then, I expect the new CEO to follow up with a reverse split (to defend share price).
I expect the trading price of IQST to exceed $2 by the end of the month & for their 10k (which will be released at that time) to pave the way for a rapid climb to $5 by the end of April. As they have stated a goal of continuing mergers & acquisitions enabled by the establishment of capital formation (dilutive), I'd expect the IQST share price to be above $10 this summer & sway with the tides of efficient growth thereafter.
$IQST is experiencing rapid revenue Growth, it has no debt, it is streamlining its subsidiaries, it has marginal Outstanding Shares, & it is determined to uplist (could have joined OTCQB last summer) & that is likely to be on the nasdaq which generally requires Share price to be $3 (but their is a $2 provision). Also, IQST has tweeted that they will make an announcement about uplisting this week & have messaged their Ambassadors group on Facebook that News is also imminent.
I'll bet that these are all demonstration trades originating from the original 30000 sold yesterday by the Revolt Token Deployer. FWIW, I expect $ALYI trading to fully indicate uncertainties until institutional investors & other venture capitalists are motivated by sector heavy weights better attuned to its analytics & their information needs.
Those who haven't established their $IQST position already still have a brief opportunity to nurse local wounds & seed future hopes.
If Elon Musk / $TSLA were to get involved with the RVLT token, one would think he or they would, in part, time such investment to advance the purchasing power of potential new EV consumers. ALYI management & investors should caution their roller coastered expectations with patience.
the new MM behemoth is borrowing from the 4.3 million shares available to raid the market.
1. a) I'd feel much better about $IQST's reconstituted Russell MicroCap (RM) inclusion if its application for uplisting to the Nasdaq, as a testament to Market Efficiency, was made on March 1 because 4 to 6 weeks of processing applies to much pressure upon RM deadlines.
2. Be very careful with price forecasts from stock promoters who are only relying upon 8 weeks of data and who are not weighting seasonal (calendar) effects (especially when they let slip their 20% profit regret)
Apparently Elon Musk doesn't like stable coins.
Or did they say pegged to the dollar? Something like that Elon Musk (@elonmusk)
20, 2021Or did they say pegged to the dollar? Something like that …
— Elon Musk (@elonmusk) February 20, 2021
I am dismayed by the lack of imaginative belief of some board posters when the 1000% run up of IQST's share price since late December 2020 is considered as an exponentiating factor for the tightening of share structure's impact on its continuing bull run (despite likely naked trading by MMs).
BTW, if you are dependent upon buy the hype & sell the news trading insights of self-styled trading gurus, then know that you are being played solely for the benefit of their portfolio gains (especially in light of the fact that IQST is in the habit of stacking its news releases for sequential release.
Behaving as confident & long-run minded shareholders will help advantage IQST in identifying & capturing enterprises which offer its subsidiaries new synergies & greater revenue. If no one sells shares until IQST is $26 it will be too expensive for some time to attract the institutional investors looking to finance expansion & diversification. It is after these dilutive SPAs occur that skilled investors keenly average up their historic purchase price on saddle for the continuing long ride up.
In short, exiting too soon entails troubling dilution & risky mergers. Holding way too long, on the other hand, will stifle growth.
If an equity firm is taking over, they may force a continued sell off and then take ALYI private before spinning out anew with an IPO. A lot of uncertainty has creeped into the forecast picture of when value multiples will occur again.
If the RevoltToken is to be valued at $1 and as 1 share of ALYI, shouldn't 1 share of ALYI be => $1 by the time of the ICO?
Nasdaq Capital Market: Financial and Liquidity Requirements
+ 6 week application process
https://listingcenter.nasdaq.com/assets/initialguide.pdf
See Requirements
* Currently traded companies qualifying solely under the Market Value Standard must meet the $50 million Market Value of Listed
Securities and the applicable bid price requirement for 90 consecutive trading days before applying.
** Effective August 2019 Nasdaq’s initial listing criteria were revised to exclude securities subject to resale restrictions for any reason from
the calculation of publicly held shares, market value of publicly held shares and round lot shareholders. In addition, the round lot
shareholder requirements were revised to also require that at least half of the minimum required number of round lot holders must each
hold unrestricted securities with a minimum value of $2,500.
*** To qualify under the closing price alternative, a company must have: (i) average annual revenues of $6 million for three years, or (ii)
net tangible assets of $5 million, or (iii) net tangible assets of $2 million and a 3 year operating history, in addition to satisfying the other
financial and liquidity requirements listed above.
Nasdaq Global Market: Financial and Liquidity Requirements |
+ 6 week application process
https://listingcenter.nasdaq.com/assets/initialguide.pdf
See requirements
*Currently traded companies qualifying solely under the Market Value Standard must meet the $75 million Market Value of Listed
Securities and the $4 bid price requirement for 90 consecutive trading days before applying.
** Effective August 2019 Nasdaq’s initial listing criteria were revised to exclude securities subject to resale restrictions for any reason from
the calculation of publicly held shares, market value of publicly held shares and round lot shareholders. In addition, the round lot
shareholder requirements were revised to also require that at least half of the minimum required number of round lot holders must each
hold unrestricted securities with a minimum value of $2,500.
In addition to the above requirements, if the security is trading in the U.S. over-the-counter market as of the date of application, the
security must have a minimum average daily trading volume of 2,000 shares (including trading volume of the underlying security on the
primary market with respect to an ADR), over the 30 trading day period prior to listing, with trading occurring on more than half of those
30 days, unless such security is listed on the Exchange in connection with a firm commitment underwritten public offering of at least $4
million.
If you are suggesting that a post uplisting leap to mid cap revenues is in the offing, I am inclined to agree. It is my belief that IQST will face an adjustment period until development of its most lucrative earnings catalyst is fully commercialized.
If I am putting numbers on my expectations, then
1) a quick ride above $7 pre-listing
2) Trading in the $5-9 range while it makes necessary business investments post-listing
3) Above $15 after its most important project is fully commercialized in 4Q 2021 & 1Q 2022
Shouldn't we expect the share price for a small cap to have its best performance & uplisted trading range established while it is a standout performer on the OTC rather than after it joins a major exchange where it will just be another face in a crowd of excellently managed & performing companies? If so, then sharp vertical movement to that plateau should occur any day now.
YAWN!!!
YAWN!!!
Electric bikes built by novices do not use super lightweight high efficiency batteries calibrated for use by sophisticated diagnostic tools & security failsafe software protecting proprietary interests of owners, users, customers, & energy services.
Whether full investigation bracketed [tld] is good or bad, my expectations & calendar are looking past placeholder indications.
Checked on my portfolio this morning & discovered my good till cancel sell order at 30.75 was executed without news. I find the idea that wallstreetbets was responsible for my realized returns extremely dubious. Seems far more likely that hedge funds are using the news cycle to price in their expectations for trial results.
GLTA
If the RevoltToken is intended to provide working capital for production of Alternet's electric vehicle fleet, then it is essential that it trades on a tight float with strong support from venture capital.
Emerging details about collaborative partners have significantly strengthened Alternet's viability, but until investment capital is plainly available for use the exponentially skyrocketing potential of share price will have dime store range limits. An approach to $2.00 by july 2021 & uplisting are definitely in play. A well played RS, at that point, could add additional multiples with global manufacturing expansions